1. Home
  2. EVBN vs NKTR Comparison

EVBN vs NKTR Comparison

Compare EVBN & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVBN
  • NKTR
  • Stock Information
  • Founded
  • EVBN 1920
  • NKTR 1990
  • Country
  • EVBN United States
  • NKTR United States
  • Employees
  • EVBN N/A
  • NKTR N/A
  • Industry
  • EVBN Major Banks
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVBN Finance
  • NKTR Health Care
  • Exchange
  • EVBN Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • EVBN 231.8M
  • NKTR 247.9M
  • IPO Year
  • EVBN N/A
  • NKTR 1994
  • Fundamental
  • Price
  • EVBN $43.26
  • NKTR $0.78
  • Analyst Decision
  • EVBN Hold
  • NKTR Strong Buy
  • Analyst Count
  • EVBN 2
  • NKTR 5
  • Target Price
  • EVBN $36.25
  • NKTR $4.50
  • AVG Volume (30 Days)
  • EVBN 18.4K
  • NKTR 1.5M
  • Earning Date
  • EVBN 02-11-2025
  • NKTR 03-03-2025
  • Dividend Yield
  • EVBN 3.08%
  • NKTR N/A
  • EPS Growth
  • EVBN N/A
  • NKTR N/A
  • EPS
  • EVBN 3.34
  • NKTR N/A
  • Revenue
  • EVBN $82,014,000.00
  • NKTR $93,137,000.00
  • Revenue This Year
  • EVBN N/A
  • NKTR $12.15
  • Revenue Next Year
  • EVBN $9.18
  • NKTR N/A
  • P/E Ratio
  • EVBN $12.85
  • NKTR N/A
  • Revenue Growth
  • EVBN N/A
  • NKTR 5.53
  • 52 Week Low
  • EVBN $24.07
  • NKTR $0.57
  • 52 Week High
  • EVBN $46.21
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • EVBN 53.69
  • NKTR 32.65
  • Support Level
  • EVBN $42.04
  • NKTR $0.80
  • Resistance Level
  • EVBN $44.00
  • NKTR $0.89
  • Average True Range (ATR)
  • EVBN 0.99
  • NKTR 0.06
  • MACD
  • EVBN 0.08
  • NKTR -0.01
  • Stochastic Oscillator
  • EVBN 77.05
  • NKTR 29.80

About EVBN Evans Bancorp Inc.

Evans Bancorp Inc is a financial holding company. Through its subsidiaries, it provides various banking services to consumers and commercial customers in the USA. The firm operates in two segments, Banking Activities and Insurance Agency Activities. The banking business segment includes both commercial and consumer banking services, including lending and depository services and offering non-deposit investment products, such as annuities and mutual funds. The insurance agency segment includes the activities of selling various premium-based insurance policies on a commission basis, including business and personal insurance, employee benefits, surety bonds, risk management, life, disability and long-term care coverage, and providing claims adjusting services to various insurance companies.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: